Representative before the EPO

Company dna sagittarius ip
no operation time available
1 office
active in Legal Services

We have observed 16 EP applications Peter James Ruscoe has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 28, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP15153587

Stable pharmaceutical composition comprising solifenacin, and method for preparing the same

IPC classification:
A61K 31/439, A61K 9/20
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP13786872

QUINAZOLINE BASED RESPIRATORY SYNCYTIAL VIRUS INHIBITORS

IPC classification:
A61P 31/14, A61K 31/519, A61K 31/517, C07D 471/04, C07D 413/06, C07D 413/04, C07D 407/14, C07D 403/14, C07D 403/06, C07D 401/06, C07D 413/14, C07D 401/14, C07D 487/04
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
GRANT OF PATENT INTENDED
EP14865782

METHOD FOR PURIFYING DARBEPOETIN ALFA

IPC classification:
C07K 14/505, C07K 1/18
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16165937

MICROORGANISM PRODUCING L-METHIONINE PRECURSOR AND THE METHOD OF PRODUCING L-METHIONINE PRECURSOR USING THE MICROORGANISM

IPC classification:
C12R 1/19, C12P 13/08
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP14872706

SOLID PREPARATIONS CONTAINING PELARGONIUM SIDOIDES EXTRACTS AND SILICIC ACID COMPOUND, AND PREPARING METHOD THEREOF

IPC classification:
A61P 1/00, A61K 36/185, A61K 9/16, A61K 9/20
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
EXAMINATION REQUESTED
EP16192090

COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING CNS NEUROLOGICAL INJURY

IPC classification:
A61P 25/28, A61K 38/18
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP17168874

USE OF A NEUREGULIN TO TREAT PERIPHERAL NERVE INJURY

IPC classification:
A61P 25/02, A61K 38/18
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Examination is in progress
EP17158578

ISOLATED STAPHYLOCOCCUS-SPECIFIC SOLUBLE BINDING MOLECULE

IPC classification:
C07K 14/005
Applicant:
The Rockefeller University
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP17187879

USE OF GGF2 TO TREAT PERIPHERAL NERVE INJURY

IPC classification:
A61P 25/02, A61K 38/18
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP16713874

POLYPEPTIDES

IPC classification:
C07K 16/24
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP16714360

PEPTIDE CONSTRUCT HAVING A PROTEASE-CLEAVABLE LINKER

IPC classification:
A61P 37/00, A61P 1/00, C07K 16/46, C07K 16/28, C07K 16/12, A61K 39/395
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP16714363

POLYPEPTIDE COMPRISING AN IMMUNOGLOBULIN CHAIN VARIABLE DOMAIN WHICH BINDS TO CLOSTRIDIUM DIFFICILE TOXIN B

IPC classification:
C07K 16/40, C07K 16/12, A61K 39/40, C07K 14/33
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP16714361

POLYPEPTIDES

IPC classification:
C07K 16/24, C07K 16/12
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP16821693

PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE, VALSARTAN, AND ROSUVASTATIN

IPC classification:
A61K 9/20, A61K 31/505, A61K 31/41, A61K 31/44
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
Request for examination was made
EP17209369

THERAPEUTIC DOSING OF A NEUREGULIN OR A SUBSEQUENCE THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE

IPC classification:
A61P 9/00, A61K 38/18
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
The application has been published
EP18170238

IMPROVEMENTS TO IMMOBILISED BIOLOGICAL ENTITIES

IPC classification:
A61L 33/00, A61L 31/10, A61L 27/34
Agent:
Peter James Ruscoe, Sagittarius IP
Status:
The application has been published

Please Sign in to use this feature